Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID)
CUSIP: 690469101
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 134,553,130
- Total 13F shares
- 33,589,442
- Share change
- +206,403
- Total reported value
- $112,862,212
- Put/Call ratio
- 27%
- Price per share
- $3.36
- Number of holders
- 70
- Value change
- -$90,780
- Number of buys
- 30
- Number of sells
- 43
Quarterly Holders Quick Answers
What is CUSIP 690469101?
CUSIP 690469101 identifies OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 690469101:
Top shareholders of OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
4.9%
|
6,631,051
|
$25,927,000 | — | 30 Jun 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
4.5%
|
6,082,200
|
$23,781,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.6%
|
3,505,637
|
$13,706,000 | — | 30 Jun 2021 | |
| Artal Group S.A. |
13F
|
Company |
1.9%
|
2,500,000
|
$9,775,000 | — | 30 Jun 2021 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
1.5%
|
2,000,000
|
$7,820,000 | — | 30 Jun 2021 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,838,246
|
$7,188,000 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.89%
|
1,202,730
|
$4,703,000 | — | 30 Jun 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.84%
|
1,124,872
|
$4,398,000 | — | 30 Jun 2021 | |
| GLOBEFLEX CAPITAL L P |
13F
|
Company |
0.75%
|
1,009,125
|
$3,946,000 | — | 30 Jun 2021 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.57%
|
765,650
|
$2,994,000 | — | 30 Jun 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.55%
|
745,915
|
$2,917,000 | — | 30 Jun 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.34%
|
453,617
|
$1,774,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
450,524
|
$1,761,000 | — | 30 Jun 2021 | |
| Amit Rakhit PoA |
3/4/5
|
President and CMO |
—
mixed-class rows
|
817,806
mixed-class rows
|
$1,562,669 | — | 14 Jul 2021 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.29%
|
396,870
|
$1,552,000 | — | 30 Jun 2021 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.28%
|
372,733
|
$1,457,000 | — | 30 Jun 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.25%
|
332,200
|
$1,299,000 | — | 30 Jun 2021 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.22%
|
301,767
|
$1,180,000 | — | 30 Jun 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.21%
|
288,780
|
$1,129,000 | — | 30 Jun 2021 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.19%
|
257,564
|
$1,007,000 | — | 30 Jun 2021 | |
| CHI Advisors LLC |
13F
|
Company |
0.16%
|
218,510
|
$854,000 | — | 30 Jun 2021 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
211,400
|
$827,000 | — | 30 Jun 2021 | |
| Ergoteles LLC |
13F
|
Company |
0.15%
|
197,389
|
$772,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.14%
|
190,200
|
$743,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.12%
|
156,849
|
$613,000 | — | 30 Jun 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
141,433
|
$553,000 | — | 30 Jun 2021 | |
| DCF Advisers, LLC |
13F
|
Company |
0.1%
|
139,701
|
$546,000 | — | 30 Jun 2021 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.1%
|
131,515
|
$514,000 | — | 30 Jun 2021 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.09%
|
116,760
|
$457,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.08%
|
113,572
|
$444,000 | — | 30 Jun 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.08%
|
110,180
|
$431,000 | — | 30 Jun 2021 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
106,720
|
$417,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
91,847
|
$359,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.06%
|
85,566
|
$335,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
82,052
|
$321,000 | — | 30 Jun 2021 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.06%
|
80,697
|
$316,000 | — | 30 Jun 2021 | |
| Tibra Equities Europe Ltd |
13F
|
Company |
0.06%
|
78,700
|
$308,000 | — | 30 Jun 2021 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.06%
|
76,973
|
$301,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.05%
|
69,102
|
$270,000 | — | 30 Jun 2021 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.05%
|
65,701
|
$257,000 | — | 30 Jun 2021 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.04%
|
53,935
|
$211,000 | — | 30 Jun 2021 | |
| XTX Topco Ltd |
13F
|
Company |
0.04%
|
50,569
|
$198,000 | — | 30 Jun 2021 | |
| Redmile Group, LLC |
13F
|
Company |
0.03%
|
40,674
|
$159,000 | — | 30 Jun 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.03%
|
37,961
|
$148,000 | — | 30 Jun 2021 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
37,797
|
$148,000 | — | 30 Jun 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
36,113
|
$141,000 | — | 30 Jun 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
35,227
|
$137,000 | — | 30 Jun 2021 | |
| Diversified Trust Co |
13F
|
Company |
0.03%
|
35,063
|
$137,000 | — | 30 Jun 2021 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.02%
|
28,360
|
$111,000 | — | 30 Jun 2021 | |
| LMR Partners LLP |
13F
|
Company |
0.02%
|
26,199
|
$102,000 | — | 30 Jun 2021 |
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q3 2021
As of 30 Sep 2021,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
70 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,589,442 shares.
The largest 10 holders included
BVF INC/IL, EcoR1 Capital, LLC, VANGUARD GROUP INC, Stonepine Capital Management, LLC, Artal Group S.A., ACADIAN ASSET MANAGEMENT LLC, GLOBEFLEX CAPITAL L P, BlackRock Inc., Ikarian Capital, LLC, and PLATINUM INVESTMENT MANAGEMENT LTD.
This page lists
70
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
76
Q3 2021 holders
70
Holder diff
-6
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.